Previous close | 492.26 |
Open | 493.14 |
Bid | 495.22 x 100 |
Ask | 495.66 x 100 |
Day's range | 492.17 - 502.97 |
52-week range | 340.20 - 503.99 |
Volume | |
Avg. volume | 1,181,461 |
Market cap | 127.803B |
Beta (5Y monthly) | 0.39 |
PE ratio (TTM) | 32.16 |
EPS (TTM) | 15.40 |
Earnings date | 01 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 481.41 |
Twist Bioscience (TWST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Following this sale, the insider now owns 25,539 shares of Vertex Pharmaceuticals Inc. Vertex Pharmaceuticals Inc, headquartered in Boston, Massachusetts, is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. Over the past year, Carmen Bozic has sold a total of 45,305 shares of Vertex Pharmaceuticals Inc and has not made any purchases of the stock.
Insight into Baillie Gifford (Trades, Portfolio)'s Latest 13F Filings and Portfolio Adjustments